ABCL vs AWK
Abcellera Biologics Inc (ABCL) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ABCL currently screens at market cap $1.12B. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ABCL and AWK stock pages for the full models.
Not investment advice.